Oncopeptides was established solely to develop therapies for difficult-to-treat hematological diseases, and we are committed to bringing patients the treatments they need and the hope they deserve.
This browser is no longer recommended for use by Microsoft. To optimize your security and experience on OSMOCONFERENCE website, we suggest using Google Chrome, Firefox or Microsoft Edge.